Search company, investor...

Founded Year

2014

Stage

Acq - Fin | Alive

Valuation

$0000 

Revenue

$0000 

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+40 points in the past 30 days

About Nemera

Nemera is a company that focuses on designing and manufacturing drug delivery devices in the healthcare sector. The company offers a range of services including front end innovation and device development, clinical and commercial manufacturing, and combination product services. Their products are designed to deliver drugs through various routes such as dermal, inhalation, and parenteral, among others. It was founded in 2014 and is based in La Verpilliere, France.

Headquarters Location

20 avenue de la Gare

La Verpilliere, 38292,

France

+33 (0) 4 74 94 06 54

Loading...

Loading...

Nemera Patents

Nemera has filed 92 patents.

The 3 most popular patent topics include:

  • fluid dynamics
  • medical equipment
  • dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/12/2020

8/1/2023

Safety equipment, Road safety, Firefighting equipment, Safety switches, Occupational safety and health

Grant

Application Date

5/12/2020

Grant Date

8/1/2023

Title

Related Topics

Safety equipment, Road safety, Firefighting equipment, Safety switches, Occupational safety and health

Status

Grant

Latest Nemera News

Cristalia Products with Nemera’s Reusable Pen Injector Commercialised in Brazil

Jan 31, 2024

Cristalia Products with Nemera’s Reusable Pen Injector Commercialised in Brazil 31 January 2024 Shutterstock Cristalia’s human growth hormone will be administered with CRISPEN. Approved by ANVISA1, CRISPEN is part of Nemera’s state-of- the-art pen injector platform PENDURA AD. The advantages of the pen are several, according to Monique Samaan, Cristalia’s Biotechnology Scientific Manager . “You can instantly feel the quality of our pen injector just by holding it in your hands. Its robust body gives you the stability you need during the application. When you trigger the injection, a little green ball appears indicating that it is complete, and you know you can remove the needle from the injection site. The injection has a constant flow that doesn’t require pressure, making the application smoother”, she said. CRISPEN is a reusable, spring-assisted device dedicated to the administration of the growth hormone distributed by Cristalia. Based on Nemera’s proprietary PENDURA AD development platform, CRISPEN facilitates the treatment of patients who have GH deficiency or insufficiency. The treatment can be prepared only once, in advance and can be refrigerated for up to 28 days. Before injection, a simple turn of the dial is required to choose the desired dose. This ensures administration of the drug without error. Some of the other features of CRISPEN device include automatic, spring-assisted drug delivery and lateral positioning of the button. Together, these contribute to highest safety and comfort for patients. “In the process of design of our pen injectors, safety and ease-of-use for patients play a key role. In PenDura AD platform, which was used to develop Crispen for Cristalia, we applied unique technological solutions such as ergonomic release button, low-force, spring-assisted drug delivery system as well as unambiguous user`s interface, which all were appreciated by patients all over the world. We are proud that sharing our patient-centric approach, Cristalia chose Nemera for the development of the pen for its somatropin” said Radoslaw Romanczuk, Pen Platform Business Development Director at Nemera . At Nemera, we design and manufacture devices that maximise treatment efficacy and partner with our customers in the best possible way to ultimately bring high-quality and safe treatment solutions to patients. Our partnership with Cristalia further strengthens our commitment to bringing superior value to customers and patients.

Nemera Frequently Asked Questions (FAQ)

  • When was Nemera founded?

    Nemera was founded in 2014.

  • Where is Nemera's headquarters?

    Nemera's headquarters is located at 20 avenue de la Gare, La Verpilliere.

  • What is Nemera's latest funding round?

    Nemera's latest funding round is Acq - Fin.

  • Who are the investors of Nemera?

    Investors of Nemera include Astorg Partners and Montagu Private Equity.

  • Who are Nemera's competitors?

    Competitors of Nemera include EYE-GO and 2 more.

Loading...

Compare Nemera to Competitors

D
Daikyo Seiko

Daikyo Seiko specializes in the manufacture of pharmaceutical packaging and medical device components.

Inovalon Logo
Inovalon

Inovalon is a company that focuses on providing data-driven healthcare solutions, operating in the healthcare and technology sectors. The company offers a range of services, including advanced analytics, cloud-based software solutions, and real-time data access, all aimed at improving clinical outcomes and healthcare economics. Inovalon primarily serves sectors such as healthcare providers, payers, pharmacies, and life sciences companies. It was founded in 1998 and is based in Bowie, Maryland.

B
Bormioli Pharma

Bormioli Pharma specializes in healthcare packaging solutions and is based in Italy.

W
Weidmann Group

Weidmann Group is a leading global supplier of engineered products and services in the Electrical and Medical/Pharmaceutical industries. The company specializes in developing technically advanced solutions such as transformer electrical insulation and injection-molded components for medical and pharmaceutical applications. Weidmann primarily serves the energy sector and the medical technology industry with its innovative products. It is based in Rapperswil, Switzerland.

Owen Mumford Logo
Owen Mumford

Owen Mumford designs and manufactures medical devices. The company offers devices for venepuncture, eye care, neuropathy, diabetes care, and more. It was founded in 1952 and is based in Oxfordshire, United Kingdom.

Datwyler Logo
Datwyler

Datwyler (SWX: DAE) develops Electroactive Polymer (EAP) actuator technology for pumps, valves, and haptic feedback devices. It serves the healthcare, mobility, and food and beverage industries. The company was founded in 1902 and is based in Altdorf, Switzerland.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.